A-Cal 500 mg Tab
A-Cal 500 mg TabDESCRIPTIONCalcium is an essential body electrolyte. It is involved in the maintenance of normal muscle and nerve function, cardiac function and is essential to blood coagulation.Calcium Carbonate has three main actions: it supplements dietary calcium, neutralizes gastric acid in peptic ulcer disease and sequesters phosphorous in the intestine to reduce total body phosphate accumulation in chronic renal failure. Calcium requirement varies with age and is relatively greater in childhood, pregnancy and lactation dueto an increased demand, in old age due to impaired absorption, and as phosphate binder in patients with renal failure. Absorption depends on previous intake of calcium, other nutrients, pregnancy, lactation, overall calcium balance and availability of vitamin D.COMPOSITIONA-CAL 250 chewable : Each chewable tablet contains Calcium Carbonate BP 0.625 g equivalent to 250 mg elemental Calcium. A-CAL 250 : Each film-coated tablet contains Calcium Carbonate BP 0.625 g equivalent to 250 mg elemental Calcium. A-CAL 500 : Each film-coated tablet contains Calcium Carbonate BP 1.25 g equivalent to 500 mg elemental Calcium.INDICATIONSIn calcium deficiency states : Treatment of calcium deficiency states including osteomalacia, rickets and mal-absorption syndromes affecting the upper gastrointestinal tract.As therapeutic supplementation : During times when intake may be inadequate, particularly those associated with the increased demand of childhood, old age, pregnancy and lactation. As a phosphate binder : As effective phosphate binder given by mouth to reduce phosphate absorption from the gut in patient with hyperphosphataemia, chronic renal failure in order to prevent the development of renal osteo-dystrophy. Osteoporosis : An adjunct to conventional therapy in the arrest or slowing down of bone demineralisation in osteoporosis or when other effective treatment is contraindicated. As an antacid : Usually in association with other antacids, especially magnesium containing antacids.DOSAGE AND ADMINISTRATIONA-Cal 250 :Adults : 2 tablets daily.Children : 1-2 tablets daily.A-Cal 500 : 1 tablet daily.OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSMild gastrointestinal disturbances may occur rarely (e.g. nausea, abdominal pain, constipation, flatulence and eructation etc.)CONTRAINDICATIONSCalcium Carbonate is contraindicated in hypercalcemia and hyperparathyroidism, hypercalcemia and nephrolithiasis, Zollinger Ellison Syndrome etc.PRECAUTIONSShould be used with caution in patients with impaired renal function, a history of stone formation should also be recommended to increase their fluid intake. High doses of vitamin D should be avoided during calcium therapy unless specially indicated. In case of hypercalciuria the dosage should be reduced or treatment stopped.USE IN PREGNANCY AND LACTATIONCalcium supplements have been in wide use for many years without apparent ill consequence.DRUG INTERACTIONSCalcium Carbonate and other antacids may interfere with the absorption of concomitantly administered tetracycline preparations or ciprofloxacin. This can be minimized by giving Calcium Carbonate and the other medication 2 to 3 hours apart.SUPPLYA-CAL 250 chewable : Each box contains 3 X 10 tablets in blisterstrips.A-CAL 250 : Each box contains 10 X 10 tablets in blister strips.A-CAL 500 : Each box contains 10 X 10 tablets in blister strips...
Tk.5.00/=
A-Cal 500/400 IU Tablet DX 30's pack
A-Cal 500/400 IU Tablet DX 30's packDESCRIPTIONA-Cal DX tablet is a special preparation of Calcium and Vitamin D3. Calcium is an essential nutrient that helps to build and maintain healthy teeth and bones. It makes body’s framework stronger by building bone.COMPOSITIONEach film-coated tablet contains Calcium Carbonate BP equivalent to elemental Calcium 500 mg and Vitamin D3 (Cholecalciferol) BP 400 IU.INDICATIONFor the prevention and/or treatment of osteoporosis,fractures,osteomalacia,rickets,tetany,pse udo-parathyroidism, for healthy bone formation and maintenance and other calcium and/or vitamin D deficiencies and to meet increased needs of calcium and/or vitamin D. Dosage and Administration: The recommended starting dose of A-Cal DX (Calcium 500 mg & Vitamin D 400 IU) 1 tablet twice daily, preferably with or just after meals.SIDE EFFECTSThe use of calcium supplements may cause constipation, and headache; mild hypercalcemia associated with anorexia, nausea and vomiting; more severe hypercalcemia associated with confusion, delirium, stupor and coma. The use of vitamin D may cause weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain, metallic taste, polyuria, polydipsia, anorexia, weight loss, nocturia and mild acidosis. CONTRAINDICATION A-Cal DX is contraindicated in patients Having hyperalcaemia, severe hypercalciurea, ventricular fibrillation, hypervitaminosis, severe renal failure and kidney stones and hypersensitivity to any of the ingredients of the product.PRECAUTIONPatients with mild to moderate renal failure or mild hypercalciuria should be supervised carefully. Periodic checks of plasma calcium levels and urinary calcium excretion should be made in patient with a history of renal stones or in patients with mild to moderate renal failure or mild hypercalciuria. USE IN PREGNANCY AND LACTATION A-Cal DX should be used under the direction of a physician during pregnancy and lactation. During pregnancy, doses of vitamin D greater than the recommended dietary allowance should be used only when clearly needed.DRUG INTERACTIONCo-administration of calcium with some drugs such as tetracycline antibiotics (e.g., doxycycline, minocycline), estramustine, levothyroxine, and quinolone antibiotics (e.g. ciprofloxacin, levofloxacin) can decrease the absorption of both calcium and the co-administered drug. Certain medications can decrease the absorption of vitamin D e.g., bile acid sequestrates such as cholestyramine/colestipol, ketoconazole, mineral oil, orlistat. Certain drugs can accelerate the absorption of vitamin D e.g. phenytonin, phenobarbital.SUPPLYEach plastic container contains 30 tablets...
Tk.225.00/=
A-Cal D 30s Tab
A-Cal D 30s TabDESCRIPTIONA-CAL D tablet is a special preparation of Calcium and Vitamin D3. Calcium is an essential nutrient that helps to build and maintain healthy teeth and bones. It makes body's framework stronger by building bone. Most notably, Calcium helps to reduce the risk of osteoporosis, a disease that's characterized by a decrease in bone mass and an increase in bone fractures. Calcium also plays a role in muscle contraction, blood clotting and nerve function.Vitamin D3 is essential for healthy bones as it aids in calcium absorption from the GI tract. In addition to this it stimulates bone formation. Controlled clinical studies showed that Calcium and Vitamin D3 has synergistic effects on bone growth as well as in osteoporosis and fracture prevention.COMPOSITIONEach film-coated tablet contains elemental Calcium 500 mg and Vitamin D3 200 IU.INDICATIONSPrevention and treatment of osteoporosis and fractures (both vertebral and non-vertebral); treatment of osteomalacia, rickets, tetany, hypoparathyroidism and secondary hyperparathyroidism; in kidney disease, pancreatitis, hyperoxaluria; as phosphate binder to reduce phosphate absorption in patients with hyperphosphatemia; during therapy with antiseizure medications, bisphosphonates in paget's disease; for healthy bone formation and maintenance; in disorders of osteogenesis and tooth formation (in addition to specific treatment); inpregnancy and lactation due to increased demand; in raised calcium requirement for children and adolescents at times of rapid growth; to prevent and cure calcium deficiency and/or vitamin D deficiency especially in the household people who do not get direct sunlight. DOSAGE AND ADMINISTRATION Adults, Elderly and children: 1 tablet twice daily. OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSThe use of calcium supplements may cause constipation, and headache; mild hypercalcemia associated with anorexia, nausea and vomiting; more severe hypercalcemia associated with confusion, delirium, stupor and coma. The use of vitamin D may cause weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain, metallic taste, polyuria, polydipsia, anorexia, weight loss, nocturia and mild acidosis.PRECAUTIONSPatients with mild to moderate renal failure or mild hypercalciuria should be supervised carefully. Periodic checks of plasma calcium levels and urinary calcium excretion should be made in patients with a history of renal stones or in patients with mild to moderate renal failure or mild hypercalciuria. With long term treatment it is advisable to monitor serum and urinary calcium levels and kidney function and reduce or stop treatment temporarily if serum calcium level exceeds 12 mg/dl. Calcium salt should be used cautiously in patients with sarcoidosis, history of nephrolithiasis, cardiac disease and in patients receiving cardiac glycosides.CONTRAINDICATIONSIt is contraindicated in patients having hypercalcaemia and severe hypercalciurea, ventricular fibrillation, hypervitaminosis, severe renal failure, kidney stones and hypersensitivity to any of the ingredients of the product.DRUG INTERACTIONA-CAL D should not be used with the following medications because ofpossible interactions - Iron; digoxin; verapamil; calcium, aluminium or magnesium containing antacids; other calcium or vitamin D supplements (e.g., calcitriol). Bran decreases the gastrointestinal absorption of calcium and may therefore decrease the efficacy of calcium supplements. Concurrent administration of thiazide diuretics may increase the risk of hypercalcemia. Co-administration of calcium with some drugs such as tetracycline antibiotics (e.g., doxycycline, minocycline), estramustine, levothyroxine, and quinolone antibiotics (e.g., ciprofloxacin, levofloxacin) can decrease the absorption of both calcium and the co-administered drug. Certain medications can decrease the absorption of vitamin D e.g., bile acid sequestrates such as cholestyramine/ colestipol, ketoconazole, mineral oil, orlistat. Certain drugs can accelerate the absorption of vitamin D e.g., phenytoin, phenobarbital.OVER DOSAGEIf calcium supplements are taken at overdose for long time then hypercalcimia and hypercalciuria may rise. Symptoms of overdosage of vitamin D supplements include weakness, lassitude, impaired memory, dementia, depression, paranoia, hallucinations, delirium and coma. In case of overdose supplement should be discontinued. Treatment includes saline administration, furosemide diuresis and sometimes corticosteroids.USE IN PREGNANCY AND LACTATIONA-CAL D should be used under the direction of a physician during pregnancy and lactation. Vitamin D and its metabolites pass into the breast milk in limited amounts.SUPPLY30 Tablet Pack : Each airtight plastic container contains 30 tablets.15 Tablet Pack : Each airtight plastic container contains 15 tablets...
Tk.195.00/=
A-clox 500 mg cap
A-clox 500 mg capDESCRIPTIONA-CLOX is a bactericidal antibiotic that is particularly useful against penicillinase producing Staphylococci. It is a semisynthetic member of the penicillin family. It kills bacteria by interfering the synthesis of the bacterial cell wall. A-CLOX is widely used against Gram-positive bacteria.COMPOSITIONA-CLOX capsule : Each capsule contains Cloxacillin Sodium BP equivalent to Cloxacillin 500 mg.A-CLOX Powder for Syrup : Each 5 ml contains Cloxacillin Sodium BP equivalent to 125 mg Cloxacillin after reconstitution.A-CLOX 250 mg Injection : Each vial contains sterile Cloxacillin Sodium BP equivalent to 250 mg Cloxacillin.A-CLOX 500 mg Injection : Each vial contains sterile Cloxacillin Sodium BP equivalent to 500 mg Cloxacillin.INDICATIONS Respiratory tract infection : Bronchitis Bronchiectasis, otitis media, sinusitis, pneumonia, tonsillitis, pharyngitis. Skin and soft tissue infections : Cellulitis, styes, furuncles, pemphigus, breast abscess, carbuncles, infected burns. Other infections : Osteomyelitis, acute and subacute endocarditis, urinary tract infections, obstetric infections, prophylaxis in neonatal infections.DOSAGE AND ADMINISTRATIONAdults : Oral : 500 mg six hourly ½ -1 hour before meals Intramuscular injection : 250 mg every 4-6 hours. Intravenous injection : 500 mg every 4-6 hours. In serious infections dosage may be doubled. Children (2-10 years) : 1-2 tea spoonful 6 hourly or ½ of the adult dose. Upto 2 years : ¼ of the adult dose.OR AS DIRECTED BY THE PHYSICIANInjection AdministrationFor Intramuscular injection : 250 mg and 500 mg are to be dissolved with 1.5 ml and 2 ml water for injection BP respectively before administration. For Intravenous injection : 500 mg is to be dissolved with 5-8 ml water for injection BP administered by slow injection for 3 to 4 minutes. Adequately diluted A-CLOX injection can be administered into the drip tube slowly over a period of 3 to 4 minutes.CONTRAINDICATIONSCloxacillin is contraindicated to Penicillin hypersensitive patients.SIDE EFFECTOccasional rashes, nausea, diarrhoea or indigestion may rarely be reported.SUPPLYCapsule : Box containing 1010 capsules in stripsPowder for Syrup : Bottle containing required amount of powder toprepare 100 ml syrup.A-CLOX 250 mg injection : Box contains 5 blister packs each containingone vial and one 5 ml ampoule of water for injection.A-CLOX 500 mg injection : Box contains 5 blister packs each containingone vial and one 5 ml ampoule of water for injection...
Tk.5.98/=
A-Fenac 25 mg Tab
A-Fenac 25DESCRIPTIONA-FENAC (Diclofenac Sodium) is a potent nonsteroidal, anti-inflammatory agentwith analgesic and antipyretic properties. By virtue of its analgesic, antipyreticand anti-inflammatory properties together with its excellent tolerability marks amajor advance in the treatment of rheumatic and or inflammatory conditions.Diclofenac inhibits cyclooxygenase activity with a reduction in the tissueproduction of prostaglandins.Tablet A-FENAC is enteric-coated (acid-resistant coating) with the result that the active constituent is not released until it has passed through the stomach. A-FENAC SR tablet has got many advantages. Because the frequency of drug administration is reduced, patient compliance can be improved and drug administration be made more convenient as well.COMPOSITIONTablet : Each enteric coated A-FENAC 25 tablet contains Diclofenac Sodium BP 25 mg.Each enteric coated A-FENAC 50 tablet contains Diclofenac Sodium BP 50 mg.Tablet SR : Each A-FENAC SR (sustained release) tablet contains Diclofenac Sodium BP 100 mg.Injection : Each 3 ml ampoule of A-FENAC injection contains 75 mg Diclofenac Sodium BP.Suppository : A-Fenac 12.5 : Each suppository contains declofenac sodium BP 12.5 mg.A-Fenac 50 : Each suppository contains diclofenac sodium BP 50 mg.A-FENAC Gel : Each 100 g A-FENAC Gel contains Diclofenac Diethylamine BP1.16 g equivalent to Diclofenac Sodium 1 g.INDICATIONSA-FENAC is indicated in the following cases : Rheumatoid arthritis, osteoarthritis, low back pain, injuries and manifestations of soft tissue rheumatism, ankylosing spondylitis, acute gout, control of pain & inflammation in orthopaedic, dental & other minor surgery, juvenile rheumatoid arthritis, postoperative pain, renal colic & other musculoskeletal disorders.DOSAGE & ADMINISTRATIONUsual dosing information : Tablet A-FENAC should be taken with water during or immediately after meals. Antacid should not be taken within 1-2 hours aftertaking tablet A-FENAC.Usual adult dose :A-FENAC Tablet : In adults, the initial dose is 25-50 mg three times a day, depending on the severity of the condition.A-FENAC SR Tablet : 75-150 mg once daily.Injection : For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.Suppository :Adult : 75-150 mg daily in divided doses.Children (1-12 years) : 1-3 mg/kg daily in divided dosesGel :Adult (>12 years) : A small amount (2-4 g) of A-FENAC Gel should be applied 3- 4 times daily to the affected area and rubbed lightly. Treatment is dependent on the size of the affected area. A-FENAC Gel may also be given in addition to further treatment with other dosage forms of Diclofenac.OR AS DIRECTED BY THE PHYSICIAN.CONTRAINDICATIONA-FENAC is contraindicated in peptic ulcer, previous sensitivity to Diclofenac Sodium and in asthmatic patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by Aspirin or other nonsteroidal anti-inflammatory agents with prostaglandin synthesis inhibiting activity.SIDE EFFECTSOccasional gastrointestinal disorders, headache, dizziness or vertigo, rash, elevation of SGOT/SGPT, rare peptic ulcer, gastro-intestinal bleeding, hepatitis, hypersensitivity reactions. In isolated cases, disturbances of sensation, erythema multiforme, purpura, abnormalities of renal function, blood dyscrasias may occur. PRECAUTIONSPrecaution should be taken in patients with symptoms/history of gastro-intestinal disease, impaired hepatic, cardiac or renal function, pregnancy, porphyria and patients who are taking diuretics, anticoagulant, or antidiabetics. During prolonged treatment, periodical monitoring of liver function should be carried out and blood counts are recommended. Possibility of hypersensitivity reactions to sodium disulphite particularly in patients with asthma.SUPPLYTablet :A-FENAC 25 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC 50 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC SR : Each box contains 10x10 tablets in blisters.Injection :A-FENAC : Each box contains 2x5 ampoules in blisters.Suppository :A-FENAC 12.5 : Each box contains 2x5 suppositories in blisters.A-FENAC 50 : Each box contains 2 x 5 suppositories in blisters.Gel :A-FENAC : Each tube contains 10 g gel...
Tk.0.55/=
A-Fenac 50 mg Tab
A-Fenac 50 TabDESCRIPTIONA-FENAC (Diclofenac Sodium) is a potent nonsteroidal, anti-inflammatory agentwith analgesic and antipyretic properties. By virtue of its analgesic, antipyreticand anti-inflammatory properties together with its excellent tolerability marks amajor advance in the treatment of rheumatic and or inflammatory conditions.Diclofenac inhibits cyclooxygenase activity with a reduction in the tissueproduction of prostaglandins.Tablet A-FENAC is enteric-coated (acid-resistant coating) with the result that the active constituent is not released until it has passed through the stomach. A-FENAC SR tablet has got many advantages. Because the frequency of drug administration is reduced, patient compliance can be improved and drug administration be made more convenient as well.COMPOSITIONTablet : Each enteric coated A-FENAC 25 tablet contains Diclofenac Sodium BP 25 mg.Each enteric coated A-FENAC 50 tablet contains Diclofenac Sodium BP 50 mg.Tablet SR : Each A-FENAC SR (sustained release) tablet contains Diclofenac Sodium BP 100 mg.Injection : Each 3 ml ampoule of A-FENAC injection contains 75 mg Diclofenac Sodium BP.Suppository : A-Fenac 12.5 : Each suppository contains declofenac sodium BP 12.5 mg.A-Fenac 50 : Each suppository contains diclofenac sodium BP 50 mg.A-FENAC Gel : Each 100 g A-FENAC Gel contains Diclofenac Diethylamine BP1.16 g equivalent to Diclofenac Sodium 1 g.INDICATIONSA-FENAC is indicated in the following cases : Rheumatoid arthritis, osteoarthritis, low back pain, injuries and manifestations of soft tissue rheumatism, ankylosing spondylitis, acute gout, control of pain & inflammation in orthopaedic, dental & other minor surgery, juvenile rheumatoid arthritis, postoperative pain, renal colic & other musculoskeletal disorders.DOSAGE & ADMINISTRATIONUsual dosing information : Tablet A-FENAC should be taken with water during or immediately after meals. Antacid should not be taken within 1-2 hours aftertaking tablet A-FENAC.Usual adult dose :A-FENAC Tablet : In adults, the initial dose is 25-50 mg three times a day, depending on the severity of the condition.A-FENAC SR Tablet : 75-150 mg once daily.Injection : For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.Suppository :Adult : 75-150 mg daily in divided doses.Children (1-12 years) : 1-3 mg/kg daily in divided dosesGel :Adult (>12 years) : A small amount (2-4 g) of A-FENAC Gel should be applied 3- 4 times daily to the affected area and rubbed lightly. Treatment is dependent on the size of the affected area. A-FENAC Gel may also be given in addition to further treatment with other dosage forms of Diclofenac.OR AS DIRECTED BY THE PHYSICIAN.CONTRAINDICATIONA-FENAC is contraindicated in peptic ulcer, previous sensitivity to Diclofenac Sodium and in asthmatic patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by Aspirin or other nonsteroidal anti-inflammatory agents with prostaglandin synthesis inhibiting activity.SIDE EFFECTSOccasional gastrointestinal disorders, headache, dizziness or vertigo, rash, elevation of SGOT/SGPT, rare peptic ulcer, gastro-intestinal bleeding, hepatitis, hypersensitivity reactions. In isolated cases, disturbances of sensation, erythema multiforme, purpura, abnormalities of renal function, blood dyscrasias may occur. PRECAUTIONSPrecaution should be taken in patients with symptoms/history of gastro-intestinal disease, impaired hepatic, cardiac or renal function, pregnancy, porphyria and patients who are taking diuretics, anticoagulant, or antidiabetics. During prolonged treatment, periodical monitoring of liver function should be carried out and blood counts are recommended. Possibility of hypersensitivity reactions to sodium disulphite particularly in patients with asthma.SUPPLYTablet :A-FENAC 25 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC 50 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC SR : Each box contains 10x10 tablets in blisters.Injection :A-FENAC : Each box contains 2x5 ampoules in blisters.Suppository :A-FENAC 12.5 : Each box contains 2x5 suppositories in blisters.A-FENAC 50 : Each box contains 2 x 5 suppositories in blisters.Gel :A-FENAC : Each tube contains 10 g gel...
Tk.0.84/=
A-Fenac 50mg Suppository
A-Fenac 50mg suppDESCRIPTIONA-FENAC (Diclofenac Sodium) is a potent nonsteroidal, anti-inflammatory agentwith analgesic and antipyretic properties. By virtue of its analgesic, antipyreticand anti-inflammatory properties together with its excellent tolerability marks amajor advance in the treatment of rheumatic and or inflammatory conditions.Diclofenac inhibits cyclooxygenase activity with a reduction in the tissueproduction of prostaglandins.Tablet A-FENAC is enteric-coated (acid-resistant coating) with the result that the active constituent is not released until it has passed through the stomach. A-FENAC SR tablet has got many advantages. Because the frequency of drug administration is reduced, patient compliance can be improved and drug administration be made more convenient as well.COMPOSITIONTablet : Each enteric coated A-FENAC 25 tablet contains Diclofenac Sodium BP 25 mg.Each enteric coated A-FENAC 50 tablet contains Diclofenac Sodium BP 50 mg.Tablet SR : Each A-FENAC SR (sustained release) tablet contains Diclofenac Sodium BP 100 mg.Injection : Each 3 ml ampoule of A-FENAC injection contains 75 mg Diclofenac Sodium BP.Suppository : A-Fenac 12.5 : Each suppository contains declofenac sodium BP 12.5 mg.A-Fenac 50 : Each suppository contains diclofenac sodium BP 50 mg.A-FENAC Gel : Each 100 g A-FENAC Gel contains Diclofenac Diethylamine BP1.16 g equivalent to Diclofenac Sodium 1 g.INDICATIONSA-FENAC is indicated in the following cases : Rheumatoid arthritis, osteoarthritis, low back pain, injuries and manifestations of soft tissue rheumatism, ankylosing spondylitis, acute gout, control of pain & inflammation in orthopaedic, dental & other minor surgery, juvenile rheumatoid arthritis, postoperative pain, renal colic & other musculoskeletal disorders.DOSAGE & ADMINISTRATIONUsual dosing information : Tablet A-FENAC should be taken with water during or immediately after meals. Antacid should not be taken within 1-2 hours aftertaking tablet A-FENAC.Usual adult dose :A-FENAC Tablet : In adults, the initial dose is 25-50 mg three times a day, depending on the severity of the condition.A-FENAC SR Tablet : 75-150 mg once daily.Injection : For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.Suppository :Adult : 75-150 mg daily in divided doses.Children (1-12 years) : 1-3 mg/kg daily in divided dosesGel :Adult (>12 years) : A small amount (2-4 g) of A-FENAC Gel should be applied 3- 4 times daily to the affected area and rubbed lightly. Treatment is dependent on the size of the affected area. A-FENAC Gel may also be given in addition to further treatment with other dosage forms of Diclofenac.OR AS DIRECTED BY THE PHYSICIAN.CONTRAINDICATIONA-FENAC is contraindicated in peptic ulcer, previous sensitivity to Diclofenac Sodium and in asthmatic patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by Aspirin or other nonsteroidal anti-inflammatory agents with prostaglandin synthesis inhibiting activity.SIDE EFFECTSOccasional gastrointestinal disorders, headache, dizziness or vertigo, rash, elevation of SGOT/SGPT, rare peptic ulcer, gastro-intestinal bleeding, hepatitis, hypersensitivity reactions. In isolated cases, disturbances of sensation, erythema multiforme, purpura, abnormalities of renal function, blood dyscrasias may occur. PRECAUTIONSPrecaution should be taken in patients with symptoms/history of gastro-intestinal disease, impaired hepatic, cardiac or renal function, pregnancy, porphyria and patients who are taking diuretics, anticoagulant, or antidiabetics. During prolonged treatment, periodical monitoring of liver function should be carried out and blood counts are recommended. Possibility of hypersensitivity reactions to sodium disulphite particularly in patients with asthma.SUPPLYTablet :A-FENAC 25 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC 50 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC SR : Each box contains 10x10 tablets in blisters.Injection :A-FENAC : Each box contains 2x5 ampoules in blisters.Suppository :A-FENAC 12.5 : Each box contains 2x5 suppositories in blisters.A-FENAC 50 : Each box contains 2 x 5 suppositories in blisters.Gel :A-FENAC : Each tube contains 10 g gel...
Tk.14.10/=
A-Fenac K 50 mg Tablet
A-Fenac K 50DESCRIPTIONA-FENAC K (Diclofenac Potassium) has a rapid onset of action, which makes it particularly suitable for the treatment of acute painful and inflammatory conditions. Inhibition of prostaglandin biosynthesis is considered to be fundamental to its mechanism of action. Diclofenac is rapidly and completely absorbed from A-FENAC K tablets. The absorption sets in immediately after administration.COMPOSITIONTablet : Each film-coated tablet contains Diclofenac Potassium INN 50 mg.INDICATIONSShort term treatment in the following acute conditions:• Post-traumatic pain, inflammation and swelling e.g., due to sprains.• Post-operative pain, inflammation and swelling, e.g., following dental or orthopaedic surgery.• Painful and/or inflammatory conditions in gynaecology, e.g., primary dysmenorrhoea.l• Painful syndromes of the vertebral column.• Non articular rheumatism.As an adjuvant in several painful inflammatory infections of the ear, nose or throat :• Pharyngotonsillitis.• Otitis media.DOSAGE AND ADMINISTRATIONAdults : The recommended initial daily dosage is 100-150 mg daily in 2-3 divided doses. In milder cases as well as for patients over 14 years 75-100 mg daily in 2-3 divided doses. In dysmenorrhoea the daily dosage should be individually adjusted and is generally 50- 150 mg. Children : It is not recommended for use in children. OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSOccasional epigastric pain, other gastrointestinal disorders such as nausea, vomiting, diarrhoea, abdominal cramps, dyspepsia, flatulence, anorexia etc. Occasional CNS problems such as headache, dizziness, vertigo etc.CONTRAINDICATIONSGastric or intestinal ulcer. Known hypersensitivity to the active substance or the excipients. Like other NSAIDs, Diclofenac Potassium is also contraindicated in active or suspected peptic ulcer or gastro-intestinal bleeding. Asthmatic patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid or other nonsteroidal anti-inflammatory agents with possessing prosta-glandin synthetase inhibiting activity.PRECAUTIONSSymptoms or history of gastro-intestinal disease, impaired hepatic, cardiac or renal function. Use with caution in elderly patients.SUPPLYTablet : Each box contains 5 x 10 tablets in blisters...
Tk.3.01/=
A-Fenac SR Tablet 100 mg , 1 strip
A-Fenac SRDESCRIPTIONA-FENAC (Diclofenac Sodium) is a potent nonsteroidal, anti-inflammatory agentwith analgesic and antipyretic properties. By virtue of its analgesic, antipyreticand anti-inflammatory properties together with its excellent tolerability marks amajor advance in the treatment of rheumatic and or inflammatory conditions.Diclofenac inhibits cyclooxygenase activity with a reduction in the tissueproduction of prostaglandins.Tablet A-FENAC is enteric-coated (acid-resistant coating) with the result that the active constituent is not released until it has passed through the stomach. A-FENAC SR tablet has got many advantages. Because the frequency of drug administration is reduced, patient compliance can be improved and drug administration be made more convenient as well.COMPOSITIONTablet : Each enteric coated A-FENAC 25 tablet contains Diclofenac Sodium BP 25 mg.Each enteric coated A-FENAC 50 tablet contains Diclofenac Sodium BP 50 mg.Tablet SR : Each A-FENAC SR (sustained release) tablet contains Diclofenac Sodium BP 100 mg.Injection : Each 3 ml ampoule of A-FENAC injection contains 75 mg Diclofenac Sodium BP.Suppository : A-Fenac 12.5 : Each suppository contains declofenac sodium BP 12.5 mg.A-Fenac 50 : Each suppository contains diclofenac sodium BP 50 mg.A-FENAC Gel : Each 100 g A-FENAC Gel contains Diclofenac Diethylamine BP1.16 g equivalent to Diclofenac Sodium 1 g.INDICATIONSA-FENAC is indicated in the following cases : Rheumatoid arthritis, osteoarthritis, low back pain, injuries and manifestations of soft tissue rheumatism, ankylosing spondylitis, acute gout, control of pain & inflammation in orthopaedic, dental & other minor surgery, juvenile rheumatoid arthritis, postoperative pain, renal colic & other musculoskeletal disorders.DOSAGE & ADMINISTRATIONUsual dosing information : Tablet A-FENAC should be taken with water during or immediately after meals. Antacid should not be taken within 1-2 hours aftertaking tablet A-FENAC.Usual adult dose :A-FENAC Tablet : In adults, the initial dose is 25-50 mg three times a day, depending on the severity of the condition.A-FENAC SR Tablet : 75-150 mg once daily.Injection : For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.Suppository :Adult : 75-150 mg daily in divided doses.Children (1-12 years) : 1-3 mg/kg daily in divided dosesGel :Adult (>12 years) : A small amount (2-4 g) of A-FENAC Gel should be applied 3- 4 times daily to the affected area and rubbed lightly. Treatment is dependent on the size of the affected area. A-FENAC Gel may also be given in addition to further treatment with other dosage forms of Diclofenac.OR AS DIRECTED BY THE PHYSICIAN.CONTRAINDICATIONA-FENAC is contraindicated in peptic ulcer, previous sensitivity to Diclofenac Sodium and in asthmatic patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by Aspirin or other nonsteroidal anti-inflammatory agents with prostaglandin synthesis inhibiting activity.SIDE EFFECTSOccasional gastrointestinal disorders, headache, dizziness or vertigo, rash, elevation of SGOT/SGPT, rare peptic ulcer, gastro-intestinal bleeding, hepatitis, hypersensitivity reactions. In isolated cases, disturbances of sensation, erythema multiforme, purpura, abnormalities of renal function, blood dyscrasias may occur. PRECAUTIONSPrecaution should be taken in patients with symptoms/history of gastro-intestinal disease, impaired hepatic, cardiac or renal function, pregnancy, porphyria and patients who are taking diuretics, anticoagulant, or antidiabetics. During prolonged treatment, periodical monitoring of liver function should be carried out and blood counts are recommended. Possibility of hypersensitivity reactions to sodium disulphite particularly in patients with asthma.SUPPLYTablet :A-FENAC 25 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC 50 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC SR : Each box contains 10x10 tablets in blisters.Injection :A-FENAC : Each box contains 2x5 ampoules in blisters.Suppository :A-FENAC 12.5 : Each box contains 2x5 suppositories in blisters.A-FENAC 50 : Each box contains 2 x 5 suppositories in blisters.Gel :A-FENAC : Each tube contains 10 g gel...
Tk.30.10/=
A-Fenac12.5mg suppositore
A-Fenac12.5mg suppositoreDESCRIPTIONA-FENAC (Diclofenac Sodium) is a potent nonsteroidal, anti-inflammatory agentwith analgesic and antipyretic properties. By virtue of its analgesic, antipyreticand anti-inflammatory properties together with its excellent tolerability marks amajor advance in the treatment of rheumatic and or inflammatory conditions.Diclofenac inhibits cyclooxygenase activity with a reduction in the tissueproduction of prostaglandins.Tablet A-FENAC is enteric-coated (acid-resistant coating) with the result that the active constituent is not released until it has passed through the stomach. A-FENAC SR tablet has got many advantages. Because the frequency of drug administration is reduced, patient compliance can be improved and drug administration be made more convenient as well.COMPOSITIONTablet : Each enteric coated A-FENAC 25 tablet contains Diclofenac Sodium BP 25 mg.Each enteric coated A-FENAC 50 tablet contains Diclofenac Sodium BP 50 mg.Tablet SR : Each A-FENAC SR (sustained release) tablet contains Diclofenac Sodium BP 100 mg.Injection : Each 3 ml ampoule of A-FENAC injection contains 75 mg Diclofenac Sodium BP.Suppository : A-Fenac 12.5 : Each suppository contains declofenac sodium BP 12.5 mg.A-Fenac 50 : Each suppository contains diclofenac sodium BP 50 mg.A-FENAC Gel : Each 100 g A-FENAC Gel contains Diclofenac Diethylamine BP1.16 g equivalent to Diclofenac Sodium 1 g.INDICATIONSA-FENAC is indicated in the following cases : Rheumatoid arthritis, osteoarthritis, low back pain, injuries and manifestations of soft tissue rheumatism, ankylosing spondylitis, acute gout, control of pain & inflammation in orthopaedic, dental & other minor surgery, juvenile rheumatoid arthritis, postoperative pain, renal colic & other musculoskeletal disorders.DOSAGE & ADMINISTRATIONUsual dosing information : Tablet A-FENAC should be taken with water during or immediately after meals. Antacid should not be taken within 1-2 hours aftertaking tablet A-FENAC.Usual adult dose :A-FENAC Tablet : In adults, the initial dose is 25-50 mg three times a day, depending on the severity of the condition.A-FENAC SR Tablet : 75-150 mg once daily.Injection : For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.Suppository :Adult : 75-150 mg daily in divided doses.Children (1-12 years) : 1-3 mg/kg daily in divided dosesGel :Adult (>12 years) : A small amount (2-4 g) of A-FENAC Gel should be applied 3- 4 times daily to the affected area and rubbed lightly. Treatment is dependent on the size of the affected area. A-FENAC Gel may also be given in addition to further treatment with other dosage forms of Diclofenac.OR AS DIRECTED BY THE PHYSICIAN.CONTRAINDICATIONA-FENAC is contraindicated in peptic ulcer, previous sensitivity to Diclofenac Sodium and in asthmatic patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by Aspirin or other nonsteroidal anti-inflammatory agents with prostaglandin synthesis inhibiting activity.SIDE EFFECTSOccasional gastrointestinal disorders, headache, dizziness or vertigo, rash, elevation of SGOT/SGPT, rare peptic ulcer, gastro-intestinal bleeding, hepatitis, hypersensitivity reactions. In isolated cases, disturbances of sensation, erythema multiforme, purpura, abnormalities of renal function, blood dyscrasias may occur. PRECAUTIONSPrecaution should be taken in patients with symptoms/history of gastro-intestinal disease, impaired hepatic, cardiac or renal function, pregnancy, porphyria and patients who are taking diuretics, anticoagulant, or antidiabetics. During prolonged treatment, periodical monitoring of liver function should be carried out and blood counts are recommended. Possibility of hypersensitivity reactions to sodium disulphite particularly in patients with asthma.SUPPLYTablet :A-FENAC 25 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC 50 : Each box contains 10x10 enteric coated tablets in blisters.A-FENAC SR : Each box contains 10x10 tablets in blisters.Injection :A-FENAC : Each box contains 2x5 ampoules in blisters.Suppository :A-FENAC 12.5 : Each box contains 2x5 suppositories in blisters.A-FENAC 50 : Each box contains 2 x 5 suppositories in blisters.Gel :A-FENAC : Each tube contains 10 g gel...
Tk.8.07/=
A-Migel 30 gm Gel
A-Migel 30 gm GelDescriptionMiconazole is a synthetic imidazole anti-fungal agent with a broadspectrum of activity against pathogenic fungi (including yeast and dermatophytes) and gram-positive bacteria (Staphylococcus and Streptococcus spp). It may act by interfering with the permeability of the fungal cell membranes. Miconazole oral gel is incompletely absorbed from the gastrointestinal tract. Miconazole is inactivated in the body and 10-20% of an oral dose is excreted in the urine.CompositionEach gram oral gel contains 20 mg Miconazole USP.IndicationOral treatment and prevention of fungal infections of the oropharynx and gastrointestinal tract.Dosage and AdministrationFor oral administration : Dosage is based on 15 mg/kg/day after meal. Adults : 1-2 tea-spoonfuls of gel four times daily.Children aged 6 years and over : One tea-spoonful of gel four times daily.Children aged 2-6 years : One tea-spoonful of gel twice daily. Infants under 2 years : Half tea-spoonful of gel twice daily. For localised lesions of the mouth, a small amount of A-Migel oral gel may be applied directly to the affected area with a clean finger 2-4 times daily. For topical treatment of the oropharynx, the gel should be kept in the mouth for as long as possible. Treatment should be continued for up to 2 days after the symptoms have cleared. For oral candidiasis, dental prostheses should be removed at night and brushed with the gel.OR AS DIRECTED BY THE PHYSICIANSide effectsOccasionally, nausea and vomiting have been reported and with long term treatment, diarrhoea is also reported.ContraindicationsMiconazole is contraindicated in patients with known hypersensitivity to the active drug and imidazole group.PrecautionThe concomitant use of Miconazole with anti-coagulant, anti-epileptic and anti-diabetic drugs increases the affectivity of these drugs. So dosage of Miconazole should be revised.Use in Pregnancy & LactationIn animals Miconazole has shown no teratogenic effects but is foetotoxic at high oral doses. However, as with other imidazoles, Miconazole Oral Gel should be avoided in pregnant women if possible. The potential hazards should be balanced against the possible benefits. It is not known whether Miconazole is excreted in human milk. Caution should be exercised when prescribing Miconazole Oral Gel to nursing mothers.Over dosageIn general, Miconazole is not highly toxic. In the event of accidental over dosage, vomiting and diarrhoea may occur.SupplyOral Gel : Each carton contains 15 gm oral gel in tube and a spoon...
Tk.90.00/=
Ace 125 Suppository
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. ..
Tk.4.00/=
Ace 250 Suppository
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. ..
Tk.5.00/=
Ace 500 Suppository
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. ..
Tk.8.06/=
Ace 500 mg Tablet
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace®Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack...
Tk.1.20/=
Ace Plus Tablet
Indication: Fever, headache, migraine, muscle ache, backache, toothache & menstrual pain.Dosage & Administration:Adults: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily. Not recommended for children below 12 years.Preparation: Each box contains 200 tablets of Paracetamol 500 mg & Caffeine 65 mg in a blister pack...
Tk.2.51/=
Ace XR Tablet
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. 123456789 ..
Tk.1.51/=
Acetram Tab
Indication: Management of moderate to moderately sever pain in adults & also indicated for the short-term (five days or less) management of acute. Dosage & Administration:Acetram tablet can be administered without regard to food. For the management of pain, the recommended dose is 1 or 2 tablets every 4 to 6 hours as needed for pain relief up to a maximum of 8 tablets per day. In case of short-term (five days or less) management of acute pain, the recommended dose is 2 tablets every 4 to 6 hours as needed for pain relief up to maximum of 8 tablets per day. Preparation: Each box contains 30 tablets of Paracetamol 325 mg & Tramadol Hydrochloride 37.5 mg in a blister pack. ..
Tk.8.03/=
Aclobet 0.05% Ointment 10 gm tube
Aclobet 0.05% Ointment 10 gm tubeCOMPOSITIONAclobet Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg.Aclobet Cream : Each gram contains Clobetasol Propionate BP 0.5 mg.PHARMACOLOGYClobetasol Propionate is a highly potent topical steroid. It has both local anti-inflammatory and immunosuppressive activity. Clobetasol, as the Propionate salt, is only used topically on the skin and its effects are limited to the local anti-inflammatory activity. When given systemically it has standard glucocorticoid activity and binds with high affinity to the glucocorticoid receptor. Clobetasol Propionate inhibits the adherence of neutrophils and monocyte-macrophages to the capillary endothelial cells inflammed area. Clobetasol blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin.INDICATIONSAclobet is indicated in :• Initial control of all forms of hyperacute eczema in all age groups (in children for no longer than a few days).• Chronic hyperkeratotic eczema of the hands and feet and patches of chronic lichen simplex.• Chronic hyperkeratotic psoriasis of any area of the body.• Severe acute photosensitivity.• Hypertrophic lichen planus.• Localized bullous disorders.• Keloid scarring.• Pretibial myxoedema.• Vitiligo.• Suppression of reaction after cryotherapy.DOSAGE AND ADMINISTRATIONRoute of AdministrationApply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations, therapy should be discontinued when control is achieved. If a longer course is necessary, it is recommended that treatment should not be continued for more than four weeks without the patients condition being observed. Repeated short courses of Aclobet may be used to control exacerbations. If continuous steroid treatment is necessary a less potent preparation should be used. In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effects of Aclobet can be enhanced, if necessary, by occluding the treatment area with polythene film. Only overnight occlusion is usually adequate to bring about a satisfactory response. Thereafter, improvement can usually be maintained by application without occlusion.CONTRAINDICATIONS AND PRECAUTIONClobetasol Propionate is contraindicated in :• Cutaneous infections such as impetigo, tinea corporis and herpes simplex.• Infestations such as scabies.• Neonates.• Acne Vulgaris.• Rosacea.• Gravitational ulceration.Long term continuous therapy with Clobetasol Propionate should be avoided, particularly in infants and children, in whom adrenal suppression occurs readily. If Clobetasol Propionate is required for use in children, it is recommended that the treatment should be reviewed on weekly basis. It should be noted that the infant’s napkin might act asocclusive dressing. The face more than other area of the body, may exhibit atrophic changes after prolonged treatment with potent topical corticosteroids. This must be borne in mind when treating facial conditions which warrants use of Clobetasol Propionate and frequent observation of the patient is important.SIDE EFFECTSCommon side effects : Provided the weekly dosage is less then 50 g in adults, any pituitary adrenal suppression is likely to be transient with a rapid return to normal values once the short course of steroid therapy has ceased. The same applies to children given proportionate dosage. Use of occlusive dressings increases the absorption of topical corticosteroids. Prolonged and intensive treatment with a highly active corticosteroid preparation may cause atrophic changes, such as thinning, striae and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or where skin folds are involved.Rare side effects :USE IN PREGNANCY & LACTATIONClobetasol Propionate should be avoided in pregnant women. Mothers using large amounts of the drug should be aware of potential excretion in milk.USE IN CHILDREN & ADOLESCENTDRUG INTERACTIONWith medicine :With food & others :OVER DOSEAcute overdose is very unlikely to occur. However, in the case of chronic over dosage or misuse, the features of hypercorticisms may appear and in this situation topical steroids should be discontinued.STORAGEStore below 300 C and dry place, protected from light. Keep all medicines out of reach of children.PACKINGAclobet Ointment : Each pack contains 10 gm Ointment in tube.Aclobet Cream : Each pack contains 10 gm Cream in tube...
Tk.50.14/=
Aclobet 10 gm cream
Aclobet 10 gm creamCOMPOSITIONAclobet Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg.Aclobet Cream : Each gram contains Clobetasol Propionate BP 0.5 mg.PHARMACOLOGYClobetasol Propionate is a highly potent topical steroid. It has both local anti-inflammatory and immunosuppressive activity. Clobetasol, as the Propionate salt, is only used topically on the skin and its effects are limited to the local anti-inflammatory activity. When given systemically it has standard glucocorticoid activity and binds with high affinity to the glucocorticoid receptor. Clobetasol Propionate inhibits the adherence of neutrophils and monocyte-macrophages to the capillary endothelial cells inflammed area. Clobetasol blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin.INDICATIONSAclobet is indicated in :• Initial control of all forms of hyperacute eczema in all age groups (in children for no longer than a few days).• Chronic hyperkeratotic eczema of the hands and feet and patches of chronic lichen simplex.• Chronic hyperkeratotic psoriasis of any area of the body.• Severe acute photosensitivity.• Hypertrophic lichen planus.• Localized bullous disorders.• Keloid scarring.• Pretibial myxoedema.• Vitiligo.• Suppression of reaction after cryotherapy.DOSAGE AND ADMINISTRATIONRoute of AdministrationApply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations, therapy should be discontinued when control is achieved. If a longer course is necessary, it is recommended that treatment should not be continued for more than four weeks without the patients condition being observed. Repeated short courses of Aclobet may be used to control exacerbations. If continuous steroid treatment is necessary a less potent preparation should be used. In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effects of Aclobet can be enhanced, if necessary, by occluding the treatment area with polythene film. Only overnight occlusion is usually adequate to bring about a satisfactory response. Thereafter, improvement can usually be maintained by application without occlusion.CONTRAINDICATIONS AND PRECAUTIONClobetasol Propionate is contraindicated in :• Cutaneous infections such as impetigo, tinea corporis and herpes simplex.• Infestations such as scabies.• Neonates.• Acne Vulgaris.• Rosacea.• Gravitational ulceration.Long term continuous therapy with Clobetasol Propionate should be avoided, particularly in infants and children, in whom adrenal suppression occurs readily. If Clobetasol Propionate is required for use in children, it is recommended that the treatment should be reviewed on weekly basis. It should be noted that the infant’s napkin might act asocclusive dressing. The face more than other area of the body, may exhibit atrophic changes after prolonged treatment with potent topical corticosteroids. This must be borne in mind when treating facial conditions which warrants use of Clobetasol Propionate and frequent observation of the patient is important.SIDE EFFECTSCommon side effects : Provided the weekly dosage is less then 50 g in adults, any pituitary adrenal suppression is likely to be transient with a rapid return to normal values once the short course of steroid therapy has ceased. The same applies to children given proportionate dosage. Use of occlusive dressings increases the absorption of topical corticosteroids. Prolonged and intensive treatment with a highly active corticosteroid preparation may cause atrophic changes, such as thinning, striae and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or where skin folds are involved.Rare side effects :USE IN PREGNANCY & LACTATIONClobetasol Propionate should be avoided in pregnant women. Mothers using large amounts of the drug should be aware of potential excretion in milk.USE IN CHILDREN & ADOLESCENTDRUG INTERACTIONWith medicine :With food & others :OVER DOSEAcute overdose is very unlikely to occur. However, in the case of chronic over dosage or misuse, the features of hypercorticisms may appear and in this situation topical steroids should be discontinued.STORAGEStore below 300 C and dry place, protected from light. Keep all medicines out of reach of children.PACKINGAclobet Ointment : Each pack contains 10 gm Ointment in tube.Aclobet Cream : Each pack contains 10 gm Cream in tube...
Tk.45.13/=
Aclobet-N 15 gm cream
Aclobet-N creamDESCRIPTIONClobetasol Propionate is a highly active corticosteroid with topical antiinflammatory activity. The major effect of Clobetasol Propionate on skin is a nonspecific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. Neomycin Sulphate is a broad spectrum antibiotic of the aminoglycoside type and is used to treat infections with bacteria. Nystatin is an antifungal medicine that kills fungi and yeasts by interfering with their cell membranes. The principle action of the preparation is based on the anti-inflammatory activity of the corticosteroid. The broad spectrum antibacterial and anti-candidal activity provided by the combination of Neomycin and Nystatin allow this effect to be utilized in the treatment of conditions which are or are likely to become infected.COMPOSITIONAclobet-N Cream : Each gram contains Clobetasol Propionate BP 0.5 mg, Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.Aclobet-N Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg,Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.INDICATIONS AND USAGE Eczema unresponsive to weak steroid cream or ointment. Other inflammatory skin disorders resistant to treatment with weaker steroid cream or ointment . Psoriasis. Any inflammatory skin disorders where secondary bacterial or candidal infection is present, suspected or likely to occur.DOSAGE AND ADMINISTRATIONAdults and children above 2 years : Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved. In very resistant lesions, especially where there is hyperkeratosis, the antiinflammatory effect of this preparation can be enhanced, if necessary, by occluding the treatment area with polythene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patients condition being reviewed. Repeated short courses of Aclobet - N may be used to control exacerbations.Elderly :This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur.Children : Under 2 years this preparation is not recommended.SIDE EFFECTSGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or when skin folds are involved.CONTRAINDICATIONSIt is contraindicated in rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (e.g herpes simplex, chickenpox), otitis externa with a perforated eardrum, hypersensitivity to the preparations.PRECAUTIONSLong term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If use in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.USE IN PREGNANCY & LACTATIONThe safe use of this preparation during pregnancy & lactation has not been established.DRUG INTERACTIONSNeomycin sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents following significant systemic absorption, if used in accordance with the recommendations systemic exposure to Neomycin Sulphate is expected to be minimal and drug interactions are unlikely to be significant. No hazardous interactions have been reported with use of Clobetasol Propionate or Nystatin.OVER DOSEAcute over dosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually. Also, consideration should be given to significant systemic absorption of Neomycin Sulphate. If this is suspected, use of the product should be stopped and the patient’s general status, hearing acuity, renal and neuromuscular functions should be monitored. Haemodialysis may reduce the serum level of Neomycin Sulphate.SUPPLYAclobet-N Cream : Each pack contains 15 gm cream in a tube.Aclobet-N Ointment : Each pack contains 15 gm ointment in a tube..
Tk.60.18/=
Aclobet-N 15 gm Oint
Aclobet-N OintDESCRIPTIONClobetasol Propionate is a highly active corticosteroid with topical antiinflammatory activity. The major effect of Clobetasol Propionate on skin is a nonspecific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. Neomycin Sulphate is a broad spectrum antibiotic of the aminoglycoside type and is used to treat infections with bacteria. Nystatin is an antifungal medicine that kills fungi and yeasts by interfering with their cell membranes. The principle action of the preparation is based on the anti-inflammatory activity of the corticosteroid. The broad spectrum antibacterial and anti-candidal activity provided by the combination of Neomycin and Nystatin allow this effect to be utilized in the treatment of conditions which are or are likely to become infected.COMPOSITIONAclobet-N Cream : Each gram contains Clobetasol Propionate BP 0.5 mg, Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.Aclobet-N Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg,Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.INDICATIONS AND USAGE Eczema unresponsive to weak steroid cream or ointment. Other inflammatory skin disorders resistant to treatment with weaker steroid cream or ointment . Psoriasis. Any inflammatory skin disorders where secondary bacterial or candidal infection is present, suspected or likely to occur.DOSAGE AND ADMINISTRATIONAdults and children above 2 years : Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved. In very resistant lesions, especially where there is hyperkeratosis, the antiinflammatory effect of this preparation can be enhanced, if necessary, by occluding the treatment area with polythene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patients condition being reviewed. Repeated short courses of Aclobet - N may be used to control exacerbations.Elderly :This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur.Children : Under 2 years this preparation is not recommended.SIDE EFFECTSGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or when skin folds are involved.CONTRAINDICATIONSIt is contraindicated in rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (e.g herpes simplex, chickenpox), otitis externa with a perforated eardrum, hypersensitivity to the preparations.PRECAUTIONSLong term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If use in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.USE IN PREGNANCY & LACTATIONThe safe use of this preparation during pregnancy & lactation has not been established.DRUG INTERACTIONSNeomycin sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents following significant systemic absorption, if used in accordance with the recommendations systemic exposure to Neomycin Sulphate is expected to be minimal and drug interactions are unlikely to be significant. No hazardous interactions have been reported with use of Clobetasol Propionate or Nystatin.OVER DOSEAcute over dosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually. Also, consideration should be given to significant systemic absorption of Neomycin Sulphate. If this is suspected, use of the product should be stopped and the patient’s general status, hearing acuity, renal and neuromuscular functions should be monitored. Haemodialysis may reduce the serum level of Neomycin Sulphate.SUPPLYAclobet-N Cream : Each pack contains 15 gm cream in a tube.Aclobet-N Ointment : Each pack contains 15 gm ointment in a tube..
Tk.65.45/=
Acme's Hartmann Solution IV Infusion 1000 ml bag
Acme's Hartmann Solution IV Infusion 1000 ml bagDESCRIPTIONACME’s Hartmann Solution is a sterile solution of Sodium Chloride, Potassium Chloride, Calcium Chloride and Sodium Lactate.COMPOSITIONEach 100ml of ACME’s Hartmann Solution contains Sodium Chloride BP 0.6 g, Potassium Chloride BP 0.04 g, Calcium Chloride BP 0.027 g and Sodium Lactate 50% solution USP equivalent to 0.32 g of Sodium Lactate. The solution contains per litre Sodium 131 mmol, Potassium 5 mmol, Calcium 2 mmol, Bicarbonate (as lactate) 29 mmol, and Chloride 111 mmol.INDICATIONSACME’s Hartmann Solution is used to treat hypovolemia caused by surgery, hemorrhage and trauma. Excessive sweating, severe diarrhoea or vomiting, excess loss of fluid by nephrotic kidneys, inadequate intake of fluid and electrolytes etc. that may lead to typical hypovolemic shock may be corrected with ACME’s Hartmann Solution. Severe plasma loss caused by intestinal obstruction, burns or other denuding conditions of the skin may be treated with ACME’s Hartmann Solution. ACME’s Hartmann Solution is mainly used as a fluid and electrolyte replenisher.DOSAGE AND ADMINISTRATIONThe volume and rate of infusion will depend upon the requirements of the patients and the judgement of the physician. The recommended flow rate is up to 100-drops/minute/70 kg body weight. ..
Tk.91.99/=
Acme's Milk of Magnesia 114ml Susp
Acme's Milk of Magnesia 114ml SuspDESCRIPTIONMagnesium Hydroxide is popularly known as Milk of Magnesia. It is a mildly acting antacid and laxative. It is poorly and slowly absorbed and acts by its osmotic properties in the luminal fluid which causes retention of fluid in the bowel. It is useful for emptying the bowel prior to surgical, radiological and colonoscopic procedures and can help to eliminate parasites following appropriate therapy and toxic material in some cases of poisoning. Magnesium Hydroxide is converted into Magnesium Chloride in the stomach without forming carbon dioxide.COMPOSITONEach 5 ml suspension contains Magnesium Hydroxide BP 400 mg.INDICATIONSACME'S MILK OF MAGNESIA is used in constipation, heart burn, gas and nausea. It is also indicated in acute and long acting constipation due to hyper acidity and peptic ulcer or stomatitis.DOSAGE AND ADMINISTRATIONAs Laxative:Adults: 2-4 Tablespoonful with a full glass of water.Children:6-11 years : 1-2 Tablespoonful with a full glass of water2-5 years : 1-3 Teaspoonful with a full glass of waterAs Antacid:Adults: 1-3 teaspoonful (5 to 15 ml) up to 4 times daily with water.Children:1-3 years : ¼ teaspoonful3-6 years : ¼-½ teaspoonful6-12 years : ½-1 teaspoonfulOR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSMagnesium Hydroxide in common with other magnesium salts may cause diarrhoea.CONTRAINDICATIONSMagnesium Hydroxide should not be administered where use of laxative is contraindicated. Long term treatment of Magnesium Hydroxide is contraindicated in patients with renal failure.PRECAUTIONSThe drug should be avoided if possible in patients with renal and hepatic failure and in those with heart block and myocardial disease. The drug may be used cautiously in pregnancy.DRUG INTERACTIONSMagnesium hydroxide can decrease the absorption of other drugs such as, digoxin, mycophenolate, phosphate supplements (e.g., potassium phosphate), tetracycline antibiotics, certain azole antifungals (ketoconazole, itraconazole), and quinolone antibiotics (e.g., ciprofloxacin, levofloxacin).SUPPLYSuspension: Each bottle contains 114 ml of suspension...
Tk.66.00/=
-170x150.jpg "Medicines")